Wavepaths
Therapeutic music platform for psychedelic-assisted therapy — founded by Imperial College researcher Mendel Kaelen, whose research established music as a primary active ingredient in psilocybin sessions.
Type: therapy
Location: London, United Kingdom
Membership: Therapist subscription; patient access through therapists
Venues: Digital platform; therapist partnerships globally
Activities: Personalized therapeutic music generation, therapist training on music in psychedelic therapy
About
Wavepaths was founded by Mendel Kaelen, whose Ph.D. research at Imperial College London established that music is not merely background in psychedelic sessions but a measurable active ingredient that predicts therapeutic outcomes.
The platform uses AI to generate personalized music for each stage of a psychedelic therapy session — from the anxious onset through the full peak and descent — adapting in real-time to therapist input about the client's emotional state. This represents a significant advance over static playlists (including the ones Kaelen himself developed for the Imperial trials).
Wavepaths is primarily a B2B platform: therapists and clinics subscribe to use it in their practice. It is being piloted in several clinical trial settings and licensed service centers.
The organization also trains therapists on how to use music therapeutically, drawing on the research basis that Kaelen's work established.
Why It Matters
If music is a primary therapeutic variable in psilocybin sessions — which Kaelen's research strongly suggests — then Wavepaths is developing the specialized tool that replaces the generic playlist. This has real implications for treatment outcomes.
